Education
About Us
Working with TipRanks
Follow Us
Gilead Sciences (GILD)
NASDAQ:GILD
GILD Analyst Ratings
Moderate Buy
17 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GILD Stock 12 Month Forecast
Average Price Target
$114.47
▲(6.90% Upside)
| Highest Price Target$140.00 | Average Price Target$114.47 | Lowest Price Target$90.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
Reiterated
03/20/25
Truist Financial
Reiterated
03/20/25
Morgan Stanley
Reiterated
03/19/25
Citi
Reiterated
03/19/25
Oppenheimer
Reiterated
03/19/25
Wells Fargo
Reiterated
03/18/25
BMO Capital
Reiterated
03/18/25
J.P. Morgan
Reiterated
03/18/25
Jefferies
Reiterated
03/18/25
Bernstein
Reiterated
03/11/25
Deutsche Bank
$73→$120
Buy
12.07%
Upside
Upgraded
02/18/25
Gilead upgraded to Buy from Hold at Deutsche BankGilead upgraded to Buy from Hold at Deutsche Bank
DBS
$100
Buy
-6.61%
Downside
Reiterated
02/17/25
Buy Recommendation for Gilead Sciences: Promising Outlook with Seladelpar Approval and Robust Drug Portfolio
Maxim Group
―
Hold
―
Reiterated
02/14/25
Maxim Group Reaffirms Their Hold Rating on Gilead Sciences (GILD)
DZ BANK AG
$108
Buy
0.86%
Upside
Upgraded
02/13/25
Gilead upgraded to Buy from Hold at DZ BankGilead upgraded to Buy from Hold at DZ Bank
Goldman Sachs
$85→$96
Hold
-10.35%
Downside
Reiterated
02/12/25
Gilead Sciences (GILD) PT Raised to $96 at Goldman SachsGoldman Sachs analyst Salveen Richter raised the price target on Gilead Sciences (NASDAQ: GILD) to $96.00 (from $85.00) while maintaining a Neutral rating.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Reiterated
03/20/25
Truist Financial
Reiterated
03/20/25
Morgan Stanley
Reiterated
03/19/25
Citi
Reiterated
03/19/25
Oppenheimer
Reiterated
03/19/25
Wells Fargo
Reiterated
03/18/25
BMO Capital
Reiterated
03/18/25
J.P. Morgan
Reiterated
03/18/25
Jefferies
Reiterated
03/18/25
Bernstein
Reiterated
03/11/25
Deutsche Bank
$73→$120
Buy
12.07%
Upside
Upgraded
02/18/25
Gilead upgraded to Buy from Hold at Deutsche BankGilead upgraded to Buy from Hold at Deutsche Bank
DBS
$100
Buy
-6.61%
Downside
Reiterated
02/17/25
Buy Recommendation for Gilead Sciences: Promising Outlook with Seladelpar Approval and Robust Drug Portfolio
Maxim Group
―
Hold
―
Reiterated
02/14/25
Maxim Group Reaffirms Their Hold Rating on Gilead Sciences (GILD)
DZ BANK AG
$108
Buy
0.86%
Upside
Upgraded
02/13/25
Gilead upgraded to Buy from Hold at DZ BankGilead upgraded to Buy from Hold at DZ Bank
Goldman Sachs
$85→$96
Hold
-10.35%
Downside
Reiterated
02/12/25
Gilead Sciences (GILD) PT Raised to $96 at Goldman SachsGoldman Sachs analyst Salveen Richter raised the price target on Gilead Sciences (NASDAQ: GILD) to $96.00 (from $85.00) while maintaining a Neutral rating.
Best Analysts Covering Gilead Sciences
Which Analyst Should I Follow If I Want to Buy GILD and Sell After:
1 Month
xxx
Success Rate
18/29 ratings generated profit
Average Return
+2.25%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.07% of your transactions generating a profit, with an average return of +2.25% per trade.
3 Months
xxx
Success Rate
18/29 ratings generated profit
Average Return
+2.99%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.07% of your transactions generating a profit, with an average return of +2.99% per trade.
1 Year
Success Rate
13/15 ratings generated profit
Average Return
+21.67%
reiterated a buy rating last month
Copying Joseph Catanzaro's trades and holding each position for 1 Year would result in 86.67% of your transactions generating a profit, with an average return of +21.67% per trade.
2 Years
xxx
Success Rate
15/15 ratings generated profit
Average Return
+40.03%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +40.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GILD Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
31
37
40
42
41
Hold
27
24
20
13
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
58
61
60
55
50
Each month's total comprises the sum of three months' worth of ratings.
GILD Financial Forecast
GILD Stock Forecast FAQ
What is GILD’s average 12-month price target, according to analysts?
Based on analyst ratings, Gilead Sciences’s 12-month average price target is $114.47.
What is GILD’s upside potential, based on the analysts’ average price target?
Gilead Sciences has 6.90% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GILD a Buy, Sell or Hold?
Gilead Sciences has a consensus rating of Moderate Buy which is based on 17 buy ratings, 6 hold ratings and 0 sell ratings.
What is Gilead Sciences’s price target?
The average price target for Gilead Sciences is $114.47. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $140.00 ,the lowest forecast is $90.00. The average price target represents 6.90% Increase from the current price of $107.08.
The highest analyst price target is $140.00 ,the lowest forecast is $90.00. The average price target represents 6.90% Increase from the current price of $107.08.
What do analysts say about Gilead Sciences?
Gilead Sciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 23 Wall Streets Analysts.
How can I buy shares of GILD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.